Lexeo Therapeutics, Inc. (LXEO) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$109.26M | -3.3% |
| 2024 | -$105.77M | -54.4% |
| 2023 | -$68.51M | -13.2% |
| 2022 | -$60.51M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$109.26M | -3.3% |
| 2024 | -$105.77M | -54.4% |
| 2023 | -$68.51M | -13.2% |
| 2022 | -$60.51M | — |